Endlyz Therapeutics
PrivateLast Round
Seed
May 7, 2026
Total Funding Raised
$18.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Endlyz Therapeutics is a biotechnology company developing disease-modifying small-molecule therapeutics to restore endo-lysosomal function for the treatment of Parkinson's disease and other neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endlyz Therapeutics Comparables
Compare Endlyz Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Retromer Therapeutics | 84% | |
| Alectos Therapeutics | 78% | |
| Scenic Biotech | 76% |
Endlyz Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 7, 2026 | ||||
| Seed | Mar 31, 2025 | ||||
| Grant | Mar 31, 2025 |
Endlyz Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Seed |
| Parkinson's UK | Seed |
| Oxford Science Enterprises | Seed |
| Centre for Drug Design and Discovery | Seed |
| AbbVie Ventures | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Oxford Science Enterprises | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2026
Raised $17.25M in early stage venture capital.
- Mar 31, 2025
Received $2.2M from The Michael J. Fox Foundation.
Endlyz Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Endlyz Therapeutics's valuation, stock price, and market status.
Is Endlyz Therapeutics a public or private company?
Endlyz Therapeutics is a private company.
What is the current stock price of Endlyz Therapeutics?
Endlyz Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Endlyz Therapeutics worth (valuation)?
Valuation information for Endlyz Therapeutics is not publicly available.
Can I buy Endlyz Therapeutics stock?
Endlyz Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Endlyz Therapeutics's last funding round?
Endlyz Therapeutics's most recent funding round was Early Stage VC on May 7, 2026.
Who are the main investors in Endlyz Therapeutics?
Key investors in Endlyz Therapeutics include SV Health Investors.
Will Endlyz Therapeutics IPO soon?
No public IPO plans have been announced for Endlyz Therapeutics.
How can I track Endlyz Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Endlyz Therapeutics's secondary market activity and sign up for updates.